Association of leprosy with HLA-DR2 in a Southern Brazilian population

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 1, 1997, Pages 51-59

  Visentainer, J E L ^a   Tsuneto, L T ^a   Serra, M F ^b   Peixoto, P R F ^b   Petzl Erler, M L ^c  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b Ctro Especialidades Sistema U   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

HLA; Leprosy; Mycobacterium leprae

Indexed keywords

MYCOBACTERIUM LEPRAE;

HLA DR2 ANTIGEN;

ADULT; ARTICLE; BRAZIL; FEMALE; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; LEPROSY; MALE; MIDDLE AGED;

ADULT; BRAZIL; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-DR2 ANTIGEN; HUMANS; LEPROSY; MALE; MIDDLE AGED;

EID: 0030628451     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-879x1997000100008     Document Type: Article

References (40)

1. Hansen A (1874). Bacillus leprae. Norsk Magazine for Laegevidenskaben, 9: 1-21.
2. Meyers WM (1992). Leprosy. Dermatologic Clinics, 10: 73-96.
3. Noordeen SK, Lopez Bravo L & Sundaresan TK (1992). Estimated number of leprosy cases in the world. Bulletin of the World Health Organization, 70: 7-10.
4. Noussitou FM (1976). Leprosy in Children. World Health Organization, Geneva, 11-28.
5. Ridley DS & Jopling WH (1966). Classification of leprosy according to immunity: A five-group system. International Journal of Leprosy, 34: 255-273.
6. Seghal VN, Jain MK & Srivastava G (1989). Evolution of the classification of leprosy. International Journal of Dermatology, 28: 161-167.
7. Schurr E, Morgan K, Gros P & Skamene E (1991). Genetics of leprosy. American Journal of Tropical Medicine and Hygiene, 44: 4-11.
8. Saad MHF, Medeiros MA, Gallo MEN & Fonseca LS (1991). Use of the anti-PGL-I antibody ELISA and the Mitsuda reaction in early diagnosis of leprosy. Brazilian Journal of Medical and Biological Research, 24: 801-805.
9. Rani R, Zaheer SA, Suresh NR, Walia R, Parida SK, Mukherjee A, Mukherjee R & Talwar GP (1992). Association of HLA antigens with differential responsiveness to Mycobacterium wvaccine in multibacillary leprosy patients. Journal of Clinical Immunology, 12: 50-55.
10. Hopkins R & Denny OE (1929). Leprosy in the United States. Journal of the American Medical Association, 92: 191-198.
11. Skamene E, Gros P, Forget A, Patel PJ & Nesbitt MN (1984). Regulation of resistance to leprosy by chromosome 1 locus in the mouse, Immunogenetics, 19: 117-124.
12. Curtis J, Akuffo-Adu H & Turk JL (1984). H-2 linked genes which modify resistance of C57BL/10 mice to subcutaneous infection with Mycobacterium lepraemurium. Infection and Immunity, 46: 635-638.
13. Abel L, Demenais F, Baule MS, Blanc M, Muller A, Raffoux C, Millan J, Bois E, Babron MC & Feingold N (1989). Genetic susceptibility to leprosy on a Caribbean island: Linkage analysis with fine markers. International Journal of Leprosy, 57: 465-471.
14. van Eden W, de Vries RRP, Mehra NK, Vaidya MC, D'Amaro J & van Rood JJ (1980). HLA segregation of tuberculoid leprosy: Confirmation of the DR2 marker. Journal of Infectious Diseases, 141: 693-701.
15. de Vries RRP, Mehra NK, Vaidya MC, Gupte MD, Khan PM & van Rood JJ (1980). HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. Tissue Antigens, 16: 294-304.
16. van Eden W, de Vries RRP, D'Amaro J, Schreuder I, Leiker DL & van Rood JJ (1982). HLA-DR associated genetic control of the type of leprosy in a population from Surinam. Human Immunology, 4: 343-350.
17. van Eden W, Gonzalez NM, de Vries RRP, Convit J & van Rood JJ (1985). HLA-linked control of predisposition to lepromatous leprosy. Journal of Infectious Diseases, 151: 9-14.
18. Izumi S, Sugiyama K, Matsumoto Y & Ohkawa S (1982). Analysis of the immunogenetic background of Japanese leprosy patients by the HLA systems. Vox Sanguinis, 42: 243-247.
19. Rea TH & Terasaki PI (1980). HLA-DR antigens in tuberculoid and lepromatous leprosy. Leprosy Review, 51: 117-123.
20. Miyanaga K, Jugi TR, Maeda H, Nakajima S & Kobayashi S (1981). Tuberculoid leprosy and HLA in Japanese. Tissue Antigens, 18: 331-334.
21. Schauf V, Ryan S, Scollard D, Jonasson O, Brown A, Nelson K, Smith T & Vithayasai V (1985). Leprosy associated with HLA-DR2 and DQw1 in the population of Northern Thailand. Tissue Antigens, 26: 243-247.
22. Ottenhoff THM, Gonzalez NM, de Vries RRP, Convit J & van Rood JJ (1984). Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population. Tissue Antigens, 24: 25-29.
23. Serjeantson SW (1983). HLA and susceptibility to leprosy, Immunological Reviews, 70: 89-112.
24. Rani R, Zaheer SA & Mukherjee R (1992). Do human leukocyte antigens have a role to play in differential manifestation of multibacillary leprosy? A study on multibacillary leprosy patients from North India. Tissue Antigens, 40: 124-127.
25. Terasaki PI & McClelland JD (1964). Microdroplet assay of human serum cytotoxins. Nature, 204: 998-1000.
26. Bodmer WF & Bodmer J (1977). Cytofluorochromasia. In: Ray JG, Hare DB & Kayhoe DE (Editors), NIAD Manual of Tissue Typing Techniques. National Institutes of Health, Bethesda, 31-34.
27. Svejgaard A, Jersild C, Nielsen S & Bodmer WF (1974). HLA-antigens and disease: statistical and genetical considerations. Tissue Antigens, 4: 95-105.
28. Levin J (1978). Estatistica Aplicada a Ciências Humanas. 2nd edn. Harper & Row do Brasil Ltda., Sāo Paulo.
29. Grumet FC, Coukell A, Bodmer JG, Bodmer WF & McDevitt HO (1971). Histocompatibility (HLA) antigens associated with systemic lupus erythematosus. New England Journal of Medicine, 285: 193-196.
30. Woolf B (1955). On estimating the relation between blood group and disease. Annals of Human Genetics, 19: 251-253.
31. Miettinen OS (1974). Proportion of disease caused or prevented by a given exposure, trait or intervention. American Journal of Epidemiology, 99: 325-332.
32. Green A (1982). The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction. Tissue Antigens, 19: 259-268.
33. de Vries RRP, Serjeantson SW & Layrisse Z (1984). Leprosy. In: Albert ED, Baur MP & Mayr WR (Editors), Histocompatibility Testing 1984. Springer Verlag, Berlin, 362-367.
34. Mutis T, Cornelisse YE, Datema G, van Del Elsen P, Ottenhoff THM & de Vries RRP (1994). Definition of a human suppressor T-cell epitope. Proceedings of the National Academy of Sciences, USA, 91: 9456-9460.
35. Nishimura Y, Kamikawaji N, Fujisawa K, Yoshizumi H, Yasunami M, Kimura A & Sasazuki T (1991). Genetic control of immune response and disease susceptibility by the HLA-DQ gene. Research of Immunology, 142: 459-466.
36. Mehra NK, Rajalingam R, Mitra DK, Taneja V & Giphart MJ (1995). Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians. International Journal of Leprosy, 63: 241-248.
37. Anderson DC, van Schooten WCA, Barry ME, Janson AAM, Buchanan TM & de Vries RRP (1988). A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science, 242: 259-261.
38. Rani R, Fernandez-Vin̄a MA, Zaheer KR & Stastny P (1993). Study of HLA class II alleles by PCR oligotyping in leprosy patients from North India. Tissue Antigens, 42: 133-137.
39. Gillis W (1989). T-Helper cell subpopulations and the immune spectrum of leprosy. International Journal of Leprosy, 57: 73-81.
40. de Vries RRP (1991). An immunogenetic view of delayed type hypersensitivity. Tubercle, 72: 161-167.